Femtosecond laser-assisted vs conventional cataract surgery

Affiliations

¹ Cataract Service, Moorfields Eye Hospital, London EC1V 2PD, UK; University College London Institute of Ophthalmology, London, UK. Electronic address: alex.day@ucl.ac.uk.
² Vienna Institute for Research in Ocular Surgery, A Karl Landsteiner Institute, Hanusch Hospital, Vienna, Austria.

Comment

Alexander C Day et al. Lancet. 2020.

. 2020 Jan 18;395(10219):170-171.

doi: 10.1016/S0140-6736(19)32622-4.

¹ Cataract Service, Moorfields Eye Hospital, London EC1V 2PD, UK; University College London Institute of Ophthalmology, London, UK. Electronic address: alex.day@ucl.ac.uk.
² Vienna Institute for Research in Ocular Surgery, A Karl Landsteiner Institute, Hanusch Hospital, Vienna, Austria.

No abstract available

Comment on

Femtosecond laser-assisted versus phacoemulsification cataract surgery (FEMCAT): a multicentre participant-masked randomised superiority and cost-effectiveness trial.
Schweitzer C, Brezin A, Cochener B, Monnet D, Germain C, Roseng S, Sitta R, Maillard A, Hayes N, Denis P, Pisella PJ, Benard A; FEMCAT study group. Schweitzer C, et al. Lancet. 2020 Jan 18;395(10219):212-224. doi: 10.1016/S0140-6736(19)32481-X. Lancet. 2020. PMID: 31954466 Clinical Trial.